NEJM This Week — December 15, 2022
Featuring articles on gene therapy for dystrophic epidermolysis bullosa, glofitamab in refractory diffuse large B-cell lymphoma, talquetamab for multiple myeloma, once-weekly semaglutide in adolescents with obesity, and on click chemistry; a review article on the risks of infection in xenotransplantation; a case report of a woman with fatigue and weight gain; and Perspective articles on a step toward interoperability of health IT, on a Covid-19 milestone attained, and on the Josephine way.
